FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887495422> ?p ?o ?g. }

• W2887495422 abstract "Multiple myeloma (MM) remains an incurable hematological malignancy. Combination regimens of conventional and novel drugs have improved patient's survival. However, most patients inevitably relapse and become refractory to the current therapeutic armamentarium. We investigated the efficacy of combining the microtubule-targeting agent STK405759 with dexamethasone or bortezomib in vitro and in vivo. STK405759 combined with dexamethasone or bortezomib had synergistic cytotoxic activity in RPMIS, CAG and MM1.S human MM cell lines through activation of caspase 2, 3, 8, 9 and PARP. These treatments remained cytotoxic in the presence of bone marrow stroma cells. In other MM cells, including cells resistant to vincristine, melphalan, mitoxantrone or dexamethasone, these combinations decreased significantly survival as compared to single agents. In in vivo studies, STK405759 disrupted existing blood vessels in xenograft tumors, acting not only as a cytotoxic agent but also as an anti-angiogenic drug. Mice treated with STK405759 in combination with dexamethasone or bortezomib resulted in greater tumor growth inhibition, increased overall response and prolonged survival as compared to as compared to BTZ or DEXA alone. Their anticancer activity was mediated by activation of apoptosis and reduction of tumor microvessel density. These preclinical studies provide the rationale for future clinical trials of STK405759, dexamethasone and bortezomib combinations to improve the outcome of multiple myeloma patients." @default.
• W2887495422 created "2018-08-22" @default.
• W2887495422 creator A5004321069 @default.
• W2887495422 creator A5011217358 @default.
• W2887495422 creator A5020491126 @default.
• W2887495422 creator A5021168486 @default.
• W2887495422 creator A5047173677 @default.
• W2887495422 creator A5052000388 @default.
• W2887495422 creator A5058925624 @default.
• W2887495422 creator A5078759064 @default.
• W2887495422 creator A5084964037 @default.
• W2887495422 creator A5090797007 @default.
• W2887495422 date "2018-07-31" @default.
• W2887495422 modified "2023-10-18" @default.
• W2887495422 title "STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models" @default.
• W2887495422 cites W1574056173 @default.
• W2887495422 cites W1576621202 @default.
• W2887495422 cites W1596326515 @default.
• W2887495422 cites W1824030076 @default.
• W2887495422 cites W1897640254 @default.
• W2887495422 cites W1972264308 @default.
• W2887495422 cites W2000763979 @default.
• W2887495422 cites W2002365224 @default.
• W2887495422 cites W2041448202 @default.
• W2887495422 cites W2042957818 @default.
• W2887495422 cites W2049991901 @default.
• W2887495422 cites W2053610685 @default.
• W2887495422 cites W2065543619 @default.
• W2887495422 cites W2067145347 @default.
• W2887495422 cites W2083792932 @default.
• W2887495422 cites W2092430089 @default.
• W2887495422 cites W2115015071 @default.
• W2887495422 cites W2148537814 @default.
• W2887495422 cites W2159679541 @default.
• W2887495422 cites W2163636540 @default.
• W2887495422 cites W2179777622 @default.
• W2887495422 cites W2220977678 @default.
• W2887495422 cites W2235523093 @default.
• W2887495422 cites W2402003835 @default.
• W2887495422 cites W2404356933 @default.
• W2887495422 cites W2467352880 @default.
• W2887495422 cites W2515931238 @default.
• W2887495422 cites W2523277769 @default.
• W2887495422 cites W2548696745 @default.
• W2887495422 cites W2553624743 @default.
• W2887495422 cites W2625253716 @default.
• W2887495422 cites W2766029952 @default.
• W2887495422 cites W2768087678 @default.
• W2887495422 cites W4233026774 @default.
• W2887495422 doi "https://doi.org/10.18632/oncotarget.25825" @default.
• W2887495422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6101139" @default.
• W2887495422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30140376" @default.
• W2887495422 hasPublicationYear "2018" @default.
• W2887495422 type Work @default.
• W2887495422 sameAs 2887495422 @default.
• W2887495422 citedByCount "4" @default.
• W2887495422 countsByYear W28874954222019 @default.
• W2887495422 countsByYear W28874954222020 @default.
• W2887495422 crossrefType "journal-article" @default.
• W2887495422 hasAuthorship W2887495422A5004321069 @default.
• W2887495422 hasAuthorship W2887495422A5011217358 @default.
• W2887495422 hasAuthorship W2887495422A5020491126 @default.
• W2887495422 hasAuthorship W2887495422A5021168486 @default.
• W2887495422 hasAuthorship W2887495422A5047173677 @default.
• W2887495422 hasAuthorship W2887495422A5052000388 @default.
• W2887495422 hasAuthorship W2887495422A5058925624 @default.
• W2887495422 hasAuthorship W2887495422A5078759064 @default.
• W2887495422 hasAuthorship W2887495422A5084964037 @default.
• W2887495422 hasAuthorship W2887495422A5090797007 @default.
• W2887495422 hasBestOaLocation W28874954221 @default.
• W2887495422 hasConcept C126322002 @default.
• W2887495422 hasConcept C143998085 @default.
• W2887495422 hasConcept C150903083 @default.
• W2887495422 hasConcept C154317977 @default.
• W2887495422 hasConcept C202751555 @default.
• W2887495422 hasConcept C207001950 @default.
• W2887495422 hasConcept C2776364478 @default.
• W2887495422 hasConcept C2776999253 @default.
• W2887495422 hasConcept C2777478702 @default.
• W2887495422 hasConcept C2778684742 @default.
• W2887495422 hasConcept C2780108899 @default.
• W2887495422 hasConcept C2780401358 @default.
• W2887495422 hasConcept C502942594 @default.
• W2887495422 hasConcept C55493867 @default.
• W2887495422 hasConcept C71924100 @default.
• W2887495422 hasConcept C86803240 @default.
• W2887495422 hasConcept C98274493 @default.
• W2887495422 hasConceptScore W2887495422C126322002 @default.
• W2887495422 hasConceptScore W2887495422C143998085 @default.
• W2887495422 hasConceptScore W2887495422C150903083 @default.
• W2887495422 hasConceptScore W2887495422C154317977 @default.
• W2887495422 hasConceptScore W2887495422C202751555 @default.
• W2887495422 hasConceptScore W2887495422C207001950 @default.
• W2887495422 hasConceptScore W2887495422C2776364478 @default.
• W2887495422 hasConceptScore W2887495422C2776999253 @default.
• W2887495422 hasConceptScore W2887495422C2777478702 @default.
• W2887495422 hasConceptScore W2887495422C2778684742 @default.
• W2887495422 hasConceptScore W2887495422C2780108899 @default.
• W2887495422 hasConceptScore W2887495422C2780401358 @default.
• W2887495422 hasConceptScore W2887495422C502942594 @default.

• next